About Us

About Us

Pureoyl Healthcare is a licensed Canadian contract manufacturer (Site License 303092) for cosmetics, NHPs, and supplements. We provide scalable R&D and production across liquid, capsule, and powder formats.

Pureoyl Healthcare provides world-class contract manufacturing and private label solutions. With elite certifications from Health Canada, the FDA, and Organic bodies, we bring your NHP, Cosmetic, and Food innovations to life.

FAQ's

Frequently Asked Questions

We pride ourselves on supporting brands at every stage of growth. While MOQs vary depending on the product category—such as liquids, capsules, or powders—we offer flexible solutions for both small-batch pilot runs and large-scale commercial distributions.

Yes. Pureoyl Healthcare is a licensed operator holding Health Canada Site License 303092. We operate under strict Good Manufacturing Practices (GMP) to ensure every product meets the highest safety and regulatory standards.

Absolutely. We have extensive experience navigating the NNHPD regulatory landscape. Our team can assist with the technical documentation required for Natural Product Number (NPN) applications and label compliance.

Yes. Whether you have a complete formula that needs scaling or just a concept, our in-house R&D team specializes in creating stable, high-efficacy formulations across cosmetics, sports nutrition, and herbal remedies.

Our manufacturing and labeling processes are specifically optimized for major e-commerce platforms. We ensure your products meet the rigorous physical and regulatory requirements for Amazon FBA, Walmart.ca, and Shopify-driven storefronts.

Lead times generally range from 4 to 8 weeks, depending on ingredient availability and the complexity of the packaging. We provide a detailed project timeline at the start of every partnership to ensure your launch stays on track.

We offer a wide range of ingredient sourcing options, including plant-based proteins and organic botanicals. Please speak with our team about your specific certification requirements during the consultation phase.